Shyra J. Miller

Laboratoire d’immunologie intégrative du cancer — France

Medicine · Health Sciences

11h-index1.8kcitations28works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neurofibromatosis and Schwannoma Cases(24), Neuroblastoma Research and Treatments(19), Sarcoma Diagnosis and Treatment(10), Microtubule and mitosis dynamics(7), Nerve injury and regeneration(4)

Publications28 total

Data from Gene Expression Analysis Identifies Potential Biomarkers of Neurofibromatosis Type 1 Including Adrenomedullin
2023Open Access
Supplement 1 from Gene Expression Analysis Identifies Potential Biomarkers of Neurofibromatosis Type 1 Including Adrenomedullin
2023Open Access
Supplementary Figures 2 - 4 from Ras-Driven Transcriptome Analysis Identifies Aurora Kinase A as a Potential Malignant Peripheral Nerve Sheath Tumor Therapeutic Target
2023Open Access
Supplementary Figure 1 from Ras-Driven Transcriptome Analysis Identifies Aurora Kinase A as a Potential Malignant Peripheral Nerve Sheath Tumor Therapeutic Target
2023Open Access
Supplementary Figure 1 from Ras-Driven Transcriptome Analysis Identifies Aurora Kinase A as a Potential Malignant Peripheral Nerve Sheath Tumor Therapeutic Target
2023Open Access
Supplementary Figures 2 - 4 from Ras-Driven Transcriptome Analysis Identifies Aurora Kinase A as a Potential Malignant Peripheral Nerve Sheath Tumor Therapeutic Target
2023Open Access
Supplement 1 from Gene Expression Analysis Identifies Potential Biomarkers of Neurofibromatosis Type 1 Including Adrenomedullin
2023Open Access
Data from Gene Expression Analysis Identifies Potential Biomarkers of Neurofibromatosis Type 1 Including Adrenomedullin
2023Open Access
Data from Ras-Driven Transcriptome Analysis Identifies Aurora Kinase A as a Potential Malignant Peripheral Nerve Sheath Tumor Therapeutic Target
2023Open Access
Data from Ras-Driven Transcriptome Analysis Identifies Aurora Kinase A as a Potential Malignant Peripheral Nerve Sheath Tumor Therapeutic Target
2023Open Access
Supplementary Tables S1 & S2 from Large-Scale Molecular Comparison of Human Schwann Cells to Malignant Peripheral Nerve Sheath Tumor Cell Lines and Tissues
2023Open Access
Data from Large-Scale Molecular Comparison of Human Schwann Cells to Malignant Peripheral Nerve Sheath Tumor Cell Lines and Tissues
2023Open Access
Supplementary Tables S1 & S2 from Large-Scale Molecular Comparison of Human Schwann Cells to Malignant Peripheral Nerve Sheath Tumor Cell Lines and Tissues
2023Open Access
Data from Large-Scale Molecular Comparison of Human Schwann Cells to Malignant Peripheral Nerve Sheath Tumor Cell Lines and Tissues
2023Open Access
A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor
Nature reviews. Cancer·2015· 476 citedOpen Access
Ras signaling and NO in oligodendrocytes modulate permeability of the blood–brain barrier
Nitric Oxide·2014
MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors
Journal of Clinical Investigation·2012· 325 cited
Ras-Driven Transcriptome Analysis Identifies Aurora Kinase A as a Potential Malignant Peripheral Nerve Sheath Tumor Therapeutic Target
Clinical Cancer Research·2012· 64 citedOpen Access
Antioxidant Rescue of Nf1/Ras-Induced Myelin and Vasculature Dysfunction
Journal of Bioresource Management·2012Open Access
Gene Expression Analysis Identifies Potential Biomarkers of Neurofibromatosis Type 1 Including Adrenomedullin
Clinical Cancer Research·2010· 44 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Nancy Ratner(26), Bruce J. Aronow(19), Walter J. Jessen(14), Tilat A. Rizvi(12), Margaret R. Wallace(11), Lan Kluwe(10), Timothy P. Cripe(9), Eduard Serra(8), Grier P. Page(7), Ami V. Patel(7), Jeffrey Ecsedy(7), Mark G. Qian(7), John P. Perentesis(7), Anil G. Jegga(6), Sérgio Kaiser(6), Meena Upadhyaya(6), Conxi Lázaro(6), David Eaves(6), Fatima Rangwala(5), Peter Ackerman(5)